FDA Investigator Joseph P Iser, MD

Joseph P Iser, MD has conducted inspections on 14 sites in 1 countries as of 03 Jan 2005. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
14
Last Inspection Date:
03 Jan 2005
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Joseph P Iser, MD:
Ana Maria Osorio, MD, Andrea A Branche, Andrea George, PhD, Angel K Sandhu, Anh M Lac, Barbara J Wilcox, PhD, Calvin B Koerner, Carl Lee, Carole L Jones, CDR Rochelle B Young, RPh, MSA, Christopher R Czajka, Daniel J Roberts, Darlene B Almogela, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin R Abaonza, Emily Shacter, Eric L Dong, BS, Gerald Feldman, Gerald M Feldman, PhD, Gerald N Mcgirl, DDS, Henry K Lau, James R Evans, Jeanne Fringer, PhD, Jeffrey M Watson, Jeffrey W Shrifter, DPM, Joan T Briones, Joanne Hosting, Joey V Quitania, Joseph Kutze, PhD, Joshua S Hunt, Karlygash I Yermukan, Kevin P Foley, Lakisha M Williams, Lance Mde Souza, MBA, Laurie P Norwood, LCDR Jennifer H Rhyu, Linda S Leja, Linh Tu, Mabel M Lee, Maida Henesian (NMI), Marie K Kinkade, Mariza M Jafary, Marsha W Major, Marshalette O Edwards, Michael Shanks, MS, Michael T Cyrus, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Min Shanmabel Liu, Monique C Lo, Nayan J Patel, Nicholas L Hunt, Nicholas Obiri, PhD, Omotunde O Osunsanmi, Peter E Baker, Peter Kessler, PhD, Raymond T Oji, Rebecca Rodriguez, Rebecca T Davis, Riley C Myers, PhD, Robert D Tollefsen, Sandra S Saniga, Scott N Lim, Serge L Beaucage, Sheilyn H Huang, Shelley H Beausoleil, Sherri J Jackson, Sidney B Priesmeyer, Stephanie A Slater, MS, Stuart W Russell, Terri L Dodds, Thea C Grome, Thomas W Gordon, Thuy T Nguyen, LCDR, Timothy C Grome, Truong Xuan Nguyen (Andy), Walden H Lee, William V Millar, Yi Wang, PhD

Joseph P Iser, MD's Documents

Publish Date Document Type Title
March, 2003 FDA 483 SRI International - Form 483, 2003-03-12
November, 2002 EIR Alza Corp - EIR, 2002-11-01
October, 2002 EIR Onyx Pharmaceuticals, Inc. - EIR, 2002-10-22
October, 2002 FDA 483 Onyx Pharmaceuticals, Inc. - Form 483, 2002-10-22
July, 2003 EIR Instiutional Animal Care and Use Committee at UCSF - EIR, 2003-07-22
March, 2003 EIR SRI International - EIR, 2003-03-12

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more